"10.1371_journal.pone.0087623","plos one","2014-02-10T00:00:00Z","Minhee Jang; Min Jung Lee; Jin Moo Lee; Chun-Sik Bae; Sung-Hoon Kim; Jong Hoon Ryu; Ik-Hyun Cho","Department of Convergence Medical Science, Kyung Hee University, Seoul, Republic of Korea; Department of Cancer Preventive Material Development, Kyung Hee University, Seoul, Republic of Korea; Department of Gynecology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea; College of Veterinary Medicine and Animal Medical Institute, Chonnam National University, Gwangju, Republic of Korea; Institute of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea; Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea; Department of Life and Nanopharmaceutical Science, Kyung Hee University, Seoul, Republic of Korea","Conceived and designed the experiments: JML CSB SHK JHR IHC. Performed the experiments: MJ MJL JHR. Analyzed the data: MJ MJL IHC. Contributed reagents/materials/analysis tools: JHR IHC. Wrote the paper: IHC.","This research was supported by a grant from the Kwang Dong Pharmaceutical Co., Ltd., Korea. KOK (Lot No. SQ12, 1,200 g) was obtained from Kwang Dong Pharmaceutical Company (Pyongtaek, Korea) and KOK was standardized with 5- hydroxymethylfurfural (9.4%) for consistency of quality by the Kwang Dong Pharmaceutical Company. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","02","Minhee Jang","MJ",7,TRUE,5,3,3,1,TRUE,TRUE,FALSE,0,NA,FALSE
